|
Q2 FY2027
As of Jul 31, 2026
|
Q1 FY2027
As of Apr 30, 2026
|
Q4 FY2026
As of Jan 31, 2026
|
Q3 FY2026
As of Oct 31, 2025
|
Q2 FY2026
As of Jul 31, 2025
|
Q1 FY2026
As of Apr 30, 2025
|
Q4 FY2025
As of Jan 31, 2025
|
Q3 FY2025
As of Oct 31, 2024
|
Q2 FY2025
As of Jul 31, 2024
|
Q1 FY2025
As of Apr 30, 2024
|
Q4 FY2024
As of Jan 31, 2024
|
Q3 FY2024
As of Oct 31, 2023
|
Q2 FY2024
As of Jul 31, 2023
|
Q1 FY2024
As of Apr 30, 2023
|
Q4 FY2023
As of Jan 31, 2023
|
Q3 FY2023
As of Oct 31, 2022
|
Q2 FY2023
As of Jul 31, 2022
|
Q1 FY2023
As of Apr 30, 2022
|
Q4 FY2022
As of Jan 31, 2022
|
Q3 FY2022
As of Oct 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investments—current | ||||||||||||||||||||
| Accounts receivable, net of allowance for doubtful accounts of $8,501 and $9,916 as of July 31, 2026 and January 31, 2026 | ||||||||||||||||||||
| Contract assets—current | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Investments—noncurrent | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Deferred contract acquisition costs—noncurrent | ||||||||||||||||||||
| Deferred tax assets—noncurrent | ||||||||||||||||||||
| Other assets—noncurrent | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Convertible senior notes—current | ||||||||||||||||||||
| Contract liabilities—current | ||||||||||||||||||||
| Operating lease liabilities—current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Contract liabilities—noncurrent | ||||||||||||||||||||
| Operating lease liabilities—noncurrent | ||||||||||||||||||||
| Deferred tax liability—noncurrent | ||||||||||||||||||||
| Other liabilities—noncurrent | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Preferred stock, $0.0001 par value; 10,000 shares authorized, 0 shares issued and outstanding as of July 31, 2026 and January 31, 2026 | ||||||||||||||||||||
| Common stock, $0.0001 par value; 500,000 shares authorized, 188,176 shares issued and outstanding as of July 31, 2026; 500,000 shares authorized, 197,765 shares issued and outstanding as of January 31, 2026 | ||||||||||||||||||||
| Treasury stock, at cost: 0 shares as of January 31, 2026; 30 shares as of January 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
